Michael Schiano
Internal Medicine · Liverpool, NYNPI 1245246933
Payments from drug & device makers
Across 93 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$411
- Novo Nordisk$198
- Gilead$172
- AstraZeneca$165
- Lilly USA, LLC$131
- GSK$115
- plus $762 from 20 others
What the payments were for
- Food & beverage$1,954100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $411 |
| Novo Nordisk | 12 | $198 |
| Gilead | 3 | $172 |
| AstraZeneca | 3 | $165 |
| Lilly USA, LLC | 8 | $131 |
| GSK | 7 | $115 |
| Avanir Pharmaceuticals, Inc. | 1 | $99 |
| Boehringer Ingelheim | 5 | $81 |
| Sumitomo Pharma America, Inc. | 4 | $74 |
| Merck | 4 | $72 |
| Acadia Pharmaceuticals Inc | 3 | $52 |
| IBSA Pharma Inc. | 3 | $47 |
| Genentech USA, Inc. | 2 | $37 |
| Novartis | 2 | $32 |
| Tolmar, Inc. | 2 | $30 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Sunovion Pharmaceuticals Inc. | 1 | $28 |
| Abbott | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Medtronic | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Echosens North America, Inc. | 1 | $17 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LOKELMA$125
How this compares
$1,954 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $13,770 |
| MyrbetriqMirabegron | 20 | $8,826 |
| EliquisApixaban | 13 | $7,337 |
| LinzessLinaclotide | 11 | $6,332 |
| Memantine Hcl | 49 | $2,525 |
| Divalproex Sodium | 14 | $2,427 |
| Ramelteon | 12 | $2,273 |
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 21 | $2,158 |
| Levothyroxine Sodium | 104 | $1,322 |
| Metoprolol Succinate | 71 | $1,116 |
| Buspirone Hcl | 58 | $1,095 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 23 | $1,087 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $1,030 |
| Oxcarbazepine | 12 | $1,029 |
| Potassium Chloride | 71 | $997 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $115 | $13,77020 claims |
| PfizerEliquis | $11 | $7,33713 claims |
| AbbVieLinzess | $411 | $6,33211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Liverpool
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.